Project Description

CEO: Robert Spignesi

Sector: Life Science Tools
Location: Lowell (Boston), MA USA
Investment Stage: Growth
Investment Status: Current
Year Invested: 2020

Rapid Micro Biosystems

Rapid Micro Biosystem’s innovative Growth Direct System® platform is the only system to automate the compendial method of microbial quality control (QC) in the manufacture of healthcare products. The Growth Direct System fully automates traditional microbial testing – detects contamination more quickly, delivering compelling economic benefits, while improving quality control processes and data integrity.

Rapid Micro Biosystems (NASDAQ:RPID) is based in Lowell, MA (US) and has a growing customer base in the US, Europe and Asia.

See Rapid Micro Biosystems related news here

Back to all companies

Endeavour Vision
Board Member

Alexander Schmitz

Endeavour Vision
Deal Team

Alexander Schmitz
Rob Barmann
Robert O'Holla